価格表

在庫・価格 : 2026年04月06日 18時40分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Cytokeratin 1, Mouse-Mono(LHK1)
データシート※最新のデータシートでない場合があります
NB100-2756SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 ml ¥41,000
(未発注)
追加

在庫・価格 : 2026年04月06日 18時40分 現在

Anti-Cytokeratin 1, Mouse-Mono(LHK1)

  • 商品コード:NB100-2756SS
  • メーカー:NOV
  • 包装:0.025ml
  • 価格: ¥41,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Gannon OM et al. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin. Cancer Res. 2013 Jan;19(2):428-41
Gannon OM et al
2013/01/01
Species: Human, Applications: IHC-P, ICC/IF PubMed
2 Hartmann-Fritsch F et al. Human amniotic fluid derived cells can competently substitute dermal fibroblasts in a tissue-engineered dermo-epidermal skin analog. Pediatr. Surg. Int. 2013 Jan;29(1):61-9
Hartmann-Fritsch F et al
2013/01/01
Species: Human, Applications: IHC, ICC/IF PubMed
3 Braziulis E et al. Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes. Tissue Eng Part C Methods 2012 Jun;18(6):464-74
Braziulis E et al
2012/01/01
Species: Human, Applications: IHC, ICC/IF PubMed
4 M端ller FB et al. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis. Hum. Mol. Genet. 2006 Apr;15(7):1133-41
M端ller FB et al
2006/01/01
Applications: ICC/IF PubMed
5 Hartmann-Fritsch F et al. A new model for preclinical testing of dermal substitutes for human skin reconstruction. Pediatr. Surg. Int. 2013 Feb;
Hartmann-Fritsch F et al
2013/01/01
Species: Human, Rat, Applications: IHC-P, ICC/IF PubMed
6 Boelsma E et al. Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Derm. Venereol. ;80(2):82-8
Boelsma E et al
Applications: PubMed
7 Machesney M et al. Activated keratinocytes in the epidermis of hypertrophic scars. Am. J. Pathol. 1998 May;152(5):1133-41
Machesney M et al
1998/01/01
PubMed
  • No.: 1
  • 文献情報:
    Gannon OM et al. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation. Clin. Cancer Res. 2013 Jan;19(2):428-41
    Gannon OM et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P, ICC/IF
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hartmann-Fritsch F et al. Human amniotic fluid derived cells can competently substitute dermal fibroblasts in a tissue-engineered dermo-epidermal skin analog. Pediatr. Surg. Int. 2013 Jan;29(1):61-9
    Hartmann-Fritsch F et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Braziulis E et al. Modified plastic compression of collagen hydrogels provides an ideal matrix for clinically applicable skin substitutes. Tissue Eng Part C Methods 2012 Jun;18(6):464-74
    Braziulis E et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    M端ller FB et al. A human keratin 10 knockout causes recessive epidermolytic hyperkeratosis. Hum. Mol. Genet. 2006 Apr;15(7):1133-41
    M端ller FB et al
    2006/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hartmann-Fritsch F et al. A new model for preclinical testing of dermal substitutes for human skin reconstruction. Pediatr. Surg. Int. 2013 Feb;
    Hartmann-Fritsch F et al
    2013/01/01
  • 備考:
    Species: Human, Rat, Applications: IHC-P, ICC/IF
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Boelsma E et al. Characterization and comparison of reconstructed skin models: morphological and immunohistochemical evaluation. Acta Derm. Venereol. ;80(2):82-8
    Boelsma E et al
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Machesney M et al. Activated keratinocytes in the epidermis of hypertrophic scars. Am. J. Pathol. 1998 May;152(5):1133-41
    Machesney M et al
    1998/01/01
  • 備考:
  • 参照:
    PubMed